DRKS00012712已完成未知
Open Label Placebo Treatment in Chronic Backpain: The Impact on Pain and Mobility
niversitätsklinikum EssenKlinik für Neurologie0 个研究点目标入组 127 人开始时间: 2017年7月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 127
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Age> 18 years, persistent back pain of the same quality for more than 12 weeks, diagnosis ensured by a specialist, voluntarily, informed consent to study participation
排除标准
- •Any history of malignancy in the past 5 years, any severe and regarding the study objectives highly influential diagnosis due to the investigator’s opinion, neurological deficits (e.g. paralysis, any severe psychological disorder (e.g. major depressive disorder, personality disorder, psychosis); Clinically not significant pain during the prior week before Baseline (referred to as a rating less than 4 on an 11-point numerical rating scale (0-10; no pain”, worst pain”).
研究者
相似试验
已完成
不适用
Pain Response to Open Label Placebo in Induced Acute Pain in Healthy Male AdultsAcute PainNCT03361579University Hospital, Basel, Switzerland35
已完成
早期 1 期
Intraarticular Lumbar Joint Corticosteroid Injection(s) as a Treatment of Chronic Low Back Pain in a Selected PopulationLow Back PainNCT01382771University of Florida28
已完成
2 期
PF-06372865 In Subjects With Chronic Low Back PainChronic Low Back PainNCT02262754Pfizer302
撤回
不适用
TENS Treatment Plus Ibuprofen for the Treatment of Acute Back Pain in the EDLow Back PainNCT02611583Albert Einstein Healthcare Network
已完成
不适用
Strategies to Assist With Management of PainChronic Low Back PainNCT03115359University of Wisconsin, Madison770